Form 4 holding
10%+ Owner
Avalyn Pharma Inc.
- Security class
- Common Stock
- Shares / value
- 1,275,486
- Estimated value
- Report date
- 01 May 2026
- Price
- Ownership
- Direct
Wellington Biomedical Innovation Master Investors (Cayman) II L.P. - 10%+ Owner at Avalyn Pharma Inc.
Issuer-level insider activity
- Role
- 10%+ Owner
- Issuer ticker
- AVLN on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Wellington Biomedical Innovation Master Investors (Cayman) II L.P. since 05 Sep 2025
Reported holdings for Wellington Biomedical Innovation Master Investors (Cayman) II L.P. in Avalyn Pharma Inc.
Form 4 holding
10%+ Owner
Avalyn Pharma Inc.
- Security class
- Series C-1 Convertible Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 01 May 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
10%+ Owner
Avalyn Pharma Inc.
- Security class
- Series D Convertible Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 01 May 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Wellington Biomedical Innovation Master Investors (Cayman) II L.P. in Avalyn Pharma Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.